GenusPlus Group Limited
GenusPlus Group Limited Fundamental Analysis
GenusPlus Group Limited (GNP.AX) shows moderate financial fundamentals with a PE ratio of 29.07, profit margin of 4.88%, and ROE of 27.29%. The company generates $1.0B in annual revenue with strong year-over-year growth of 36.30%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 64.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze GNP.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakGNP.AX struggles to generate sufficient returns from assets.
Valuation Score
ModerateGNP.AX shows balanced valuation metrics.
Growth Score
ExcellentGNP.AX delivers strong and consistent growth momentum.
Financial Health Score
ExcellentGNP.AX maintains a strong and stable balance sheet.
Profitability Score
ModerateGNP.AX maintains healthy but balanced margins.
Key Financial Metrics
Is GNP.AX Expensive or Cheap?
P/E Ratio
GNP.AX trades at 29.07 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, GNP.AX's PEG of 0.97 indicates potential undervaluation.
Price to Book
The market values GenusPlus Group Limited at 7.46 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 18.02 times EBITDA. This signals the market has high growth expectations.
How Well Does GNP.AX Make Money?
Net Profit Margin
For every $100 in sales, GenusPlus Group Limited keeps $4.88 as profit after all expenses.
Operating Margin
Core operations generate 7.17 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $27.29 in profit for every $100 of shareholder equity.
ROA
GenusPlus Group Limited generates $7.94 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
GenusPlus Group Limited produces operating cash flow of $171.78M, showing steady but balanced cash generation.
Free Cash Flow
GenusPlus Group Limited generates strong free cash flow of $153.48M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.85 in free cash annually.
FCF Yield
GNP.AX converts 11.12% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
29.07
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.97
vs 25 benchmark
P/B Ratio
Price to book value ratio
7.46
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.43
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.58
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.16
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.27
vs 25 benchmark
ROA
Return on assets percentage
0.08
vs 25 benchmark
ROCE
Return on capital employed
0.27
vs 25 benchmark
How GNP.AX Stacks Against Its Sector Peers
| Metric | GNP.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 29.07 | 25.96 | Worse (Expensive) |
| ROE | 27.29% | 1263.00% | Weak |
| Net Margin | 4.88% | -41827.00% (disorted) | Weak |
| Debt/Equity | 0.58 | 0.79 | Strong (Low Leverage) |
| Current Ratio | 1.16 | 10.05 | Neutral |
| ROA | 7.94% | -1497918.00% (disorted) | Weak |
GNP.AX outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews GenusPlus Group Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
274.62%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
180.41%
Industry Style: Cyclical, Value, Infrastructure
High GrowthFCF CAGR
173.89%
Industry Style: Cyclical, Value, Infrastructure
High Growth